查看购物车
  • Traditional Chinese
  • English
  • Japanese
全球微生物检测市场（至 2031 年）按产品（仪器、试剂和试剂盒、耗材）、技术（传统（人工计数、培养）、快速（核酸、活力））和最终用户（製药、生物技术、食品、水和环境检测）划分
市场调查报告书
商品编码
1942450

全球微生物检测市场（至 2031 年）按产品（仪器、试剂和试剂盒、耗材）、技术（传统（人工计数、培养）、快速（核酸、活力））和最终用户（製药、生物技术、食品、水和环境检测）划分

Microbiology Testing Market by Product (Instrument, Reagent & Kit, Consumable), Technology (Traditional (Manual Counting, Culture), Rapid (Nucleic Acid, Viability)), End User (Pharma, Biotech, Food, Water, Environmental Testing)-Global Forecast to 2031
出版日期: | 出版商: MarketsandMarkets | 英文 321 Pages | 订单完成后即时交付

价格

全球微生物检测市场预计将从 2026 年的 77.9 亿美元成长到 2031 年的 100.9 亿美元，预测期内复合年增长率为 5.3%。

由于食品、水和环境领域的污染风险不断增加，工业生产不断增长，以及检测技术的进步，预计市场将迎来快速成长。

调查范围
调查期 2024-2031
基准年 2025
预测期 2026-2031
单元 金额（美元）
部分 产品、技术、病原体类型、最终用户
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲

对污染控制、法规遵循和产品安全的日益重视，以及快速检测和自动化技术的创新，正在推动对准确可靠的微生物检测解决方案的需求。儘管先进检测系统的成本以及低成本解决方案的不稳定性可能会抑制市场成长，但调查方法的不断改进，以及各行业日益增长的应用，预计将推动市场扩张。

微生物检测市场-IMG1

预计在预测期内，製药和生物技术公司板块将占据最大的市场份额。

以最终用户划分，截至2025年，製药和生技公司占最大份额。製药和生物技术产业之所以占据最大份额，是因为在药物生产和生物技术研究中，污染控制、产品安全和法规遵循至关重要。这些产业高度依赖微生物检测来确保产品的无菌性、品质和安全性，尤其是生物製药、疫苗和治疗药物。来自FDA和EMA等机构的严格监管要求，规定了从原材料检验到最终产品出货的各个生产阶段都必须进行严格的微生物检测。此外，疾病的日益普及以及对新治疗方法和治疗方案需求的不断增长，持续推动对微生物检测解决方案的巨大需求，而製药和生物技术公司正是这些服务的最大用户。

“细菌产品细分市场占据最大的市场份额”

按病原体类型划分，细菌类病原体占据最大份额，这主要归因于细菌污染在各行各业的广泛存在及其影响。细菌是食品饮料、水处理和环境监测等领域最常见的污染病原体之一。它们可能导致产品腐败、疾病和品质问题，因此，为了确保产品安全、符合法规要求和保障公众健康，对细菌检测的需求十分旺盛。此外，成熟可靠的细菌病原体检测和鑑定方法，以及相关的法规要求，进一步巩固了细菌类病原体在微生物检测领域的领先地位。

预计亚太地区在预测期内将呈现最快的成长速度。

亚太地区是成长最快的市场，这主要得益于快速的工业化进程、不断增长的医疗保健投资以及各行业对污染控制日益重视。该地区食品饮料、水处理和环境监测等行业正经历显着增长，所有这些行业都需要进行广泛的微生物检测，以确保安全和符合法规要求。此外，医疗保健基础设施的改善以及人们对食品安全和公共卫生意识的提高，也推动了对检测解决方案的需求。中国、印度和东南亚等国家的政府措施和监管发展进一步促进了市场成长，而先进的自动化微生物检测技术的应用则有助于提高营运效率和准确性。这些因素共同促成了亚太地区成为微生物检测领域成长最快的市场。

北美是微生物检测领域的领先市场，这得益于其完善的法规结构，该体系催生了对检测的需求，以确保产品安全和合规性。该地区在采用先进的自动化检测解决方案方面也处于主导，这些解决方案提高了效率和准确性。此外，北美多元化的产业，包括製药、生物技术、食品和水处理等，持续需要可靠的微生物检测。该地区完善的医疗和工业基础设施，以及在研发领域的巨额投资，进一步巩固了其市场领导地位。

本报告调查了全球微生物检测市场，并提供了市场概况、影响市场成长的各种因素分析、技术和专利趋势、法律制度、案例研究、市场规模趋势和预测、按各个细分市场、地区/主要国家进行的详细分析、竞争格局以及主要企业的概况。

目录

第一章 引言

第二章执行摘要

第三章重要考察

第四章 市场概览

  • 市场动态
    • 司机
    • 抑制因素
    • 机会
    • 任务
  • 未满足的需求和閒置频段
  • 与相关市场和不同产业相关的跨领域机会
  • 一级/二级/三级公司的策略性倡议

第五章 产业趋势

  • 波特五力分析
  • 总体经济指标
  • 供应链分析
  • 价值链分析
  • 生态系分析
  • 定价分析
  • 贸易分析
  • 2026-2027 年重要会议与活动
  • 影响客户业务的趋势/颠覆性因素
  • 投资和资金筹措方案
  • 案例研究分析
  • 2025年美国关税对微生物检测市场的影响

第六章：技术进步、人工智慧的影响、专利、创新与未来应用

  • 关键新兴技术
    • 自动化多重PCR系统
    • 生物感测器
  • 互补技术
    • 食品和饮用水安全监测工具
    • 抗生素抗药性检测
  • 技术/产品蓝图
  • 专利分析
  • 未来应用
  • 人工智慧/生成式人工智慧对微生物检测市场的影响

第七章永续性和监管环境

  • 地方法规和合规性
  • 对永续性的承诺
  • 永续性影响和监管政策倡议

第八章：顾客状况与购买行为

  • 决策流程
  • 买方相关利益者和采购评估标准
  • 招募障碍和内部挑战
  • 各个终端用户产业尚未满足的需求
  • 市场盈利

第九章 微生物检测产品市场

  • 装置
    • 培养箱
    • 显微镜
    • 殖民地计数器
    • 质谱仪
    • 自动化培养系统
    • 其他的
  • 试剂和试剂盒
  • 消耗品

第十章 微生物检测市场：销售分析

  • 美国：製药培养箱的装置量

第十一章 按技术分類的微生物检测市场

  • 传统微生物学方法（TMM）
    • 培养方法
    • 显微镜
    • 人工计数法
    • 染色技术
    • 其他的
  • 快速微生物学方法（RMM）
    • 基于生长的快速微生物检测
    • 快速细胞微生物检测
    • 基于核酸的快速微生物检测
    • 基于活性的快速微生物检测

第十二章：按病原体类型分類的微生物检测市场

  • 细菌
  • 病毒
  • 真菌
  • 其他的

第十三章 微生物检测市场（依最终用户划分）

  • 製药和生物技术公司
  • 食品和饮料公司
  • 环境和水质检测
  • 化妆品和个人护理公司
  • 其他的

第十四章 各地区微生物检测市场

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十五章 竞争格局

  • 概述
  • 主要参与企业的策略/优势
  • 收入分析
  • 市占率分析
  • 公司评估矩阵：主要企业
  • 公司估值矩阵：Start-Ups/中小企业
  • 估值和财务指标
  • 品牌/产品对比
  • 竞争场景

第十六章：公司简介

  • 主要企业
    • BIOMERIEUX
    • THERMO FISHER SCIENTIFIC INC.
    • MERCK KGAA
    • BECTON, DICKINSON AND COMPANY (BD)
    • NEOGEN CORPORATION
    • QIAGEN
    • BIO-RAD LABORATORIES, INC.
    • BRUKER
    • SHIMADZU CORPORATION
    • CHARLES RIVER LABORATORIES
    • EUROFINS SCIENTIFIC
    • IDEXX
  • 其他公司
    • HARDY DIAGNOSTICS
    • CHARM SCIENCES
    • MICROBIOLOGICS
    • LIOFILCHEM SRL
    • R-BIOPHARM
    • ROMER LABS DIVISION HOLDING
    • HYGIENA LLC
    • HIMEDIA LABORATORIES
    • CONDALAB
    • E&O LABORATORIES LTD
    • MAST GROUP LTD.
    • MEDICAL WIRE & EQUIPMENT
    • HACH

第十七章调查方法

第十八章附录

Product Code: HIT 10240

The global microbiology testing market is projected to reach USD 10.09 billion by 2031, up from USD 7.79 billion in 2026, at a CAGR of 5.3% during the forecast period. The market is expected to grow rapidly due to rising contamination risks in the food, water, and environmental sectors, increased industrial production, and advances in testing technologies.

Scope of the Report
Years Considered for the Study2024-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsProduct, Technology, Pathogen Type, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

A growing focus on contamination control, regulatory compliance, and product safety, along with innovations in rapid testing and automation, is driving demand for accurate and reliable microbiology testing solutions. However, concerns about the cost of advanced testing systems and variability in low-cost solutions may restrain market growth. Nonetheless, continuous improvements in testing methodologies, coupled with increasing adoption across various industries, are expected to fuel market expansion.

Microbiology Testing Market - IMG1

The pharmaceutical & biotech companies segment is expected to have the largest market during the forecast period.

By end user, the market is segmented into pharmaceutical & biotech companies, food & beverage companies, environmental & water testing, cosmetics & personal-care companies, and other end users. In 2025, pharmaceutical & biotech companies accounted for the largest share of the market. The pharmaceutical & biotech segment is the largest in the microbiology testing market due to the critical need for contamination control, product safety, and regulatory compliance across drug manufacturing and biotechnological research. These industries rely heavily on microbiological testing to ensure the sterility, quality, and safety of their products, particularly biologics, vaccines, and therapeutic compounds. Stringent regulatory requirements, such as those from the FDA and EMA, mandate rigorous microbial testing at every stage of production, from raw material validation to final product release. Furthermore, the growing prevalence of diseases and the need for new treatments and therapies continue to drive significant demand for microbiology testing solutions, making pharmaceutical & biotech companies the largest consumers of these services.

The bacterial products segment accounted for the largest market share in the microbiology testing market.

The microbiology testing market is segmented by pathogen type into bacterial, viral, fungal, and other pathogens. The bacterial segment is the largest within this category due to the widespread presence and impact of bacterial contamination across various industries. Bacteria are among the most common pathogens in contamination issues across sectors such as food and beverage, water treatment, and environmental monitoring. Their ability to cause spoilage, disease, and quality issues drives strong demand for bacterial testing to ensure product safety, regulatory compliance, and public health. Additionally, well-established, reliable methods for detecting and identifying bacterial pathogens, along with regulatory mandates, further strengthen the dominance of the bacterial segment in microbiology testing.

The Asia Pacific is expected to be the fastest-growing market for microbiology testing during the forecast period.

The global microbiology testing market is segmented into six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa. The Asia Pacific is the fastest-growing market in the microbiology testing sector, driven by rapid industrialization, rising healthcare investments, and a growing focus on contamination control across industries. The region is seeing strong growth in sectors such as food and beverage, water treatment, and environmental monitoring, all of which require extensive microbiological testing to ensure safety and regulatory compliance. Additionally, improving healthcare infrastructure, coupled with rising awareness of food safety and public health, is driving demand for testing solutions. Government initiatives and regulatory developments in countries such as China, India, and across Southeast Asia further support market growth, while the adoption of advanced and automated microbiology testing technologies helps streamline operations and improve accuracy. These factors collectively position Asia-Pacific as the fastest-growing market for microbiology testing.

North America is the leading market for microbiology testing, driven by a strong regulatory framework that creates high demand for testing to ensure product safety and compliance. The region is a leader in adopting advanced, automated testing solutions that improve efficiency and accuracy. Additionally, North America's diverse industries, including pharmaceuticals, biotechnology, food, and water, continually require reliable microbiology testing. The region's well-established healthcare and industrial infrastructure, combined with significant investments in research and development, further solidifies its position as the market leader.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
  • By Designation: C Level: 27%, Director Level: 18%, and Others: 55%
  • By Region: North America: 51%, Europe: 21%, Asia Pacific: 18%, Latin America: 6%, and Middle East & Africa: 4%
  • Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the microbiology testing market are bioMerieux (France), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), and Neogen Corporation (US).

Research Coverage

This report examines the microbiology testing market by product, technology, pathogen type, end user, and region. It also examines key factors (drivers, restraints, opportunities, and challenges) influencing market growth and provides an in-depth analysis of the competitive landscape among market leaders. Furthermore, the report analyzes micro-markets by their individual growth trends. It forecasts market segment revenue for five major regions (and the respective countries within each region).

Reasons to Buy the Report

The report will enable established firms and smaller entrants to gauge the market's pulse, which, in turn, will help them gain a larger market share. Firms purchasing the report could use one or more of the strategies listed below to strengthen their market presence.

This report provides insights into the following pointers:

  • Analysis of key Drivers (Technological advancements in rapid microbiology testing, Increased funding for R&D, Rising food recalls due to non-compliant food products, Rising demand from cosmetics & personal care industry)
  • Restraints (Complexity in testing techniques, High Capital investments, and low cost benefit ratio)
  • Opportunities (Popularity of digital and automated testing platforms, Technological advancements in the testing industry)
  • Challenges (Operational barriers, Increasing cost of procuring microbiology testing equipment)

Market Penetration: Comprehensive information on the product portfolios offered by the top players in the microbiology testing market

Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the microbiology testing market

Market Development: Comprehensive information on lucrative emerging regions

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the microbiology testing market

Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players, such as bioMerieux (France), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), and Neogen Corporation (US)

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS

2 EXECUTIVE SUMMARY

  • 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS SHAPING MARKET
  • 2.4 FASTEST-GROWTH SEGMENTS AND EMERGING FRONTIERS
  • 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 MICROBIOLOGY TESTING MARKET OVERVIEW
  • 3.2 MICROBIOLOGY TESTING MARKET, BY PRODUCT
  • 3.3 MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY
  • 3.4 MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE
  • 3.5 MICROBIOLOGY TESTING MARKET, BY END USER
  • 3.6 MICROBIOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Technological advancements in rapid microbiology testing
      • 4.2.1.2 Increased funding for R&D
      • 4.2.1.3 Rising food recalls due to non-compliant food products
      • 4.2.1.4 Rising demand from cosmetics & personal care industry
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Complexity in testing techniques
      • 4.2.2.2 High Capital investments and low cost-benefit ratio
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Popularity of digital and automated testing platforms
      • 4.2.3.2 Technological advancements in testing industry
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Operational barriers
      • 4.2.4.2 Increasing cost of procuring microbiology testing equipment
  • 4.3 UNMET NEEDS AND WHITE SPACES
    • 4.3.1 UNMET NEEDS IN MICROBIOLOGY TESTING MARKET
    • 4.3.2 WHITE SPACE OPPORTUNITIES
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
    • 4.5.1 KEY MOVES AND STRATEGIC FOCUS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 THREAT OF SUBSTITUTES
    • 5.1.3 BARGAINING POWER OF BUYERS
    • 5.1.4 BARGAINING POWER OF SUPPLIERS
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS AND FORECAST
  • 5.3 SUPPLY CHAIN ANALYSIS
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 PRICING ANALYSIS
    • 5.6.1 AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING, BY PRODUCT
    • 5.6.2 AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING PRODUCTS, BY KEY PLAYER
    • 5.6.3 AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING PRODUCTS, BY REGION
  • 5.7 TRADE ANALYSIS
    • 5.7.1 IMPORT SCENARIO (HS CODE 3822)
    • 5.7.2 EXPORT SCENARIO (HS CODE 3822)
  • 5.8 KEY CONFERENCES & EVENTS, 2026-2027
  • 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.10 INVESTMENT & FUNDING SCENARIO
  • 5.11 CASE STUDY ANALYSIS
    • 5.11.1 YOUNGS SEAFOOD ACCELERATED FOOD TESTING WITH VIDAS
    • 5.11.2 RAPID MICROBIOLOGICAL METHOD CASE STUDY FOR ADVANCED THERAPY MEDICINAL PRODUCTS
    • 5.11.3 RAPID DETECTION METHOD OF BACTERIAL PATHOGENS IN SURFACE WATERS AND NEW RISK INDICATOR FOR WATER PATHOGENIC POLLUTION
  • 5.12 IMPACT OF 2025 US TARIFFS ON MICROBIOLOGY TESTING MARKET
    • 5.12.1 INTRODUCTION
    • 5.12.2 KEY TARIFF RATES
    • 5.12.3 PRICE IMPACT ANALYSIS
    • 5.12.4 KEY IMPACT ON COUNTRY/REGION
      • 5.12.4.1 North America
      • 5.12.4.2 Europe
      • 5.12.4.3 Asia Pacific
    • 5.12.5 IMPACT ON END-USE INDUSTRIES
      • 5.12.5.1 Pharmaceutical & biotech companies
      • 5.12.5.2 Food & beverage companies
      • 5.12.5.3 Environmental & water testing
      • 5.12.5.4 Cosmetics & personal care companies

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 KEY EMERGING TECHNOLOGIES
    • 6.1.1 AUTOMATED MULTIPLEX PCR SYSTEMS
    • 6.1.2 BIOSENSORS
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 FOOD & WATER SAFETY MONITORING TOOLS
    • 6.2.2 ANTIMICROBIAL RESISTANCE TESTING
  • 6.3 TECHNOLOGY/PRODUCT ROADMAP
  • 6.4 PATENT ANALYSIS
  • 6.5 FUTURE APPLICATION
  • 6.6 IMPACT OF AI/GENERATIVE AI ON MICROBIOLOGY TESTING MARKET
    • 6.6.1 INTRODUCTION
    • 6.6.2 TOP USE CASES AND MARKET POTENTIAL
    • 6.6.3 USE CASE
      • 6.6.3.1 Adoption of Gen AI by CarbConnect to achieve accuracy and consistency in diagnostics
    • 6.6.4 EVOLVING ADJACENT ECOSYSTEM THROUGH ADOPTION OF GEN AI

7 SUSTAINABILITY AND REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 INDUSTRY STANDARDS
  • 7.2 SUSTAINABILITY INITIATIVES
    • 7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN MICROBIOLOGY TESTING
      • 7.2.1.1 Eco-friendly initiatives
  • 7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
  • 8.5 MARKET PROFITABILITY
    • 8.5.1 REVENUE POTENTIAL
    • 8.5.2 COST DYNAMICS
    • 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

9 MICROBIOLOGY TESTING MARKET, BY PRODUCT

  • 9.1 INTRODUCTION
  • 9.2 INSTRUMENTS
    • 9.2.1 WIDESPREAD ADOPTION OF AUTOMATED AND HIGH-THROUGHPUT LABORATORY INSTRUMENTS TO SUPPORT MICROBIOLOGY TESTING DEMAND
    • 9.2.2 INCUBATORS
      • 9.2.2.1 Controlled environmental conditions to enable reliable microbial growth and detection
    • 9.2.3 MICROSCOPES
      • 9.2.3.1 Direct visualization and morphological analysis of microorganisms
    • 9.2.4 COLONY COUNTERS
      • 9.2.4.1 Accurate enumeration of microbial colonies to support quality assurance
    • 9.2.5 MASS SPECTROMETERS
      • 9.2.5.1 Rapid and accurate microbial identification through advanced mass spectrometry methods
    • 9.2.6 AUTOMATED CULTURE SYSTEMS
      • 9.2.6.1 High-throughput systems supporting standardized microbiology workflows
    • 9.2.7 OTHER INSTRUMENTS
  • 9.3 REAGENTS & KITS
    • 9.3.1 HIGH RECURRING DEMAND FOR STANDARDIZED AND READY-TO-USE REAGENTS & KITS TO SUPPORT MARKET GROWTH
  • 9.4 CONSUMABLES
    • 9.4.1 CONSISTENT HIGH-VOLUME CONSUMPTION OF DISPOSABLE LABORATORY SUPPLIES TO FUEL ROUTINE MICROBIOLOGY TESTING MARKET

10 MICROBIOLOGY TESTING MARKET: VOLUME ANALYSIS

  • 10.1 INTRODUCTION
  • 10.2 US: VOLUME OF PHARMA INCUBATOR INSTALLED BASE

11 MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY

  • 11.1 INTRODUCTION
  • 11.2 TRADITIONAL MICROBIOLOGY METHODS (TMM)
    • 11.2.1 WIDESPREAD REGULATORY ACCEPTANCE AND COST-EFFECTIVENESS TO SUPPORT CONTINUED ADOPTION
    • 11.2.2 CULTURE METHODS
      • 11.2.2.1 Continued reliance on culture-based techniques to support routine microbiology testing
    • 11.2.3 MICROSCOPY METHODS
      • 11.2.3.1 Rapid preliminary microbial screening to support contamination investigations
    • 11.2.4 MANUAL COUNTING METHODS
      • 11.2.4.1 Regulatory acceptance of plate count techniques to maintain widespread usage
    • 11.2.5 STAINING TECHNIQUES
      • 11.2.5.1 Low-cost and effective microbial differentiation methods to support quality control
    • 11.2.6 OTHER TRADITIONAL MICROBIOLOGY METHODS
  • 11.3 RAPID MICROBIOLOGY METHODS (RMM)
    • 11.3.1 RAPID MICROBIOLOGY METHODS ENABLE FASTER CONTAMINATION DETECTION AND IMPROVED TESTING EFFICIENCY
    • 11.3.2 GROWTH-BASED RAPID MICROBIOLOGY TESTING
      • 11.3.2.1 Growing demand for growth-based rapid microbiology testing to drive market growth
    • 11.3.3 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING
      • 11.3.3.1 High level of sensitivity, accuracy, and specificity associated with this method to boost market
    • 11.3.4 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING
      • 11.3.4.1 High accuracy associated with nucleic acid-based methods to favor market growth
    • 11.3.5 VIABILITY-BASED RAPID MICROBIOLOGY TESTING
      • 11.3.5.1 Near real-time detection and improved accuracy to drive demand

12 MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE

  • 12.1 INTRODUCTION
  • 12.2 BACTERIAL
    • 12.2.1 WIDESPREAD OCCURRENCE OF BACTERIAL CONTAMINATION ACROSS INDUSTRIES TO SUPPORT MARKET DOMINANCE
  • 12.3 VIRAL
    • 12.3.1 INCREASING FOCUS ON VIRAL SAFETY AND ENVIRONMENTAL SURVEILLANCE TO DRIVE SEGMENT GROWTH
  • 12.4 FUNGAL
    • 12.4.1 RISING INCIDENCE OF YEAST AND MOLD CONTAMINATION TO FUEL TESTING DEMAND
  • 12.5 OTHER PATHOGENS

13 MICROBIOLOGY TESTING MARKET, BY END USER

  • 13.1 INTRODUCTION
  • 13.2 PHARMACEUTICAL & BIOTECH COMPANIES
    • 13.2.1 STRINGENT GMP AND CONTAMINATION CONTROL REQUIREMENTS TO DRIVE TESTING DEMAND
  • 13.3 FOOD & BEVERAGE COMPANIES
    • 13.3.1 STRINGENT FOOD SAFETY REGULATIONS AND QUALITY CONTROL TO SUPPORT MARKET GROWTH
  • 13.4 ENVIRONMENTAL & WATER TESTING
    • 13.4.1 GROWING FOCUS ON WATER SAFETY AND ENVIRONMENTAL MONITORING TO DRIVE DEMAND
  • 13.5 COSMETICS & PERSONAL CARE COMPANIES
    • 13.5.1 MICROBIAL SAFETY AND PRODUCT STABILITY REQUIREMENTS TO SUPPORT MARKET GROWTH
  • 13.6 OTHER END USERS

14 MICROBIOLOGY TESTING MARKET, BY REGION

  • 14.1 INTRODUCTION
  • 14.2 NORTH AMERICA
    • 14.2.1 US
      • 14.2.1.1 Increasing adoption of technologically advanced products in US to favor market growth
    • 14.2.2 CANADA
      • 14.2.2.1 Favorable environment for R&D to drive market
  • 14.3 EUROPE
    • 14.3.1 GERMANY
      • 14.3.1.1 Increase in investments and funding by government to fuel market growth
    • 14.3.2 UK
      • 14.3.2.1 High prevalence of contaminated food to drive market
    • 14.3.3 FRANCE
      • 14.3.3.1 Rise in R&D expenditure to favor market growth
    • 14.3.4 ITALY
      • 14.3.4.1 Increased adoption of advanced diagnostic technologies and growing government healthcare investments to drive market
    • 14.3.5 SPAIN
      • 14.3.5.1 Water monitoring mandate to boost market growth
    • 14.3.6 REST OF EUROPE
  • 14.4 ASIA PACIFIC
    • 14.4.1 CHINA
      • 14.4.1.1 High-profile contamination events and export standards to propel market
    • 14.4.2 JAPAN
      • 14.4.2.1 Stringent safety laws and foodborne outbreaks to accelerate market
    • 14.4.3 INDIA
      • 14.4.3.1 Growth in private and public investments in healthcare systems to drive adoption of microbiology testing products
    • 14.4.4 SOUTH KOREA
      • 14.4.4.1 Increasing demand for infection control products to support market growth
    • 14.4.5 AUSTRALIA
      • 14.4.5.1 Increase in awareness about antimicrobial resistance to fuel market
    • 14.4.6 REST OF ASIA PACIFIC
  • 14.5 LATIN AMERICA
    • 14.5.1 BRAZIL
      • 14.5.1.1 Need for manufacturers to comply with ANVISA's rules to drive demand
    • 14.5.2 MEXICO
      • 14.5.2.1 Expanding microbiology testing capacity through trade and food safety enforcement to drive market
    • 14.5.3 REST OF LATIN AMERICA
  • 14.6 MIDDLE EAST & AFRICA

15 COMPETITIVE LANDSCAPE

  • 15.1 OVERVIEW
  • 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022-2025
  • 15.3 REVENUE ANALYSIS, 2022-2024
  • 15.4 MARKET SHARE ANALYSIS, 2025
  • 15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 15.5.1 STARS
    • 15.5.2 EMERGING LEADERS
    • 15.5.3 PERVASIVE PLAYERS
    • 15.5.4 PARTICIPANTS
    • 15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 15.5.5.1 Company footprint
      • 15.5.5.2 Regional footprint
      • 15.5.5.3 Product footprint
      • 15.5.5.4 Technology footprint
      • 15.5.5.5 End user footprint
  • 15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 15.6.1 PROGRESSIVE COMPANIES
    • 15.6.2 RESPONSIVE COMPANIES
    • 15.6.3 DYNAMIC COMPANIES
    • 15.6.4 STARTING BLOCKS
    • 15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
      • 15.6.5.1 List of startups/SMEs
      • 15.6.5.2 Competitive benchmarking of startups/SMEs
        • 15.6.5.2.1 Competitive benchmarking of startups/SMEs (1/2)
        • 15.6.5.2.2 Competitive benchmarking of startups/SMEs (2/2)
  • 15.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 15.8 BRAND/PRODUCT COMPARISON
  • 15.9 COMPETITIVE SCENARIO
    • 15.9.1 PRODUCT LAUNCHES AND APPROVALS
    • 15.9.2 DEALS
    • 15.9.3 EXPANSIONS

16 COMPANY PROFILES

  • 16.1 KEY PLAYERS
    • 16.1.1 BIOMERIEUX
      • 16.1.1.1 Business overview
      • 16.1.1.2 Products offered
      • 16.1.1.3 Recent developments
        • 16.1.1.3.1 Product launches and approvals
        • 16.1.1.3.2 Deals
      • 16.1.1.4 MnM view
        • 16.1.1.4.1 Right to win
        • 16.1.1.4.2 Strategic choices
        • 16.1.1.4.3 Weaknesses and competitive threats
    • 16.1.2 THERMO FISHER SCIENTIFIC INC.
      • 16.1.2.1 Business overview
      • 16.1.2.2 Products offered
      • 16.1.2.3 Recent developments
        • 16.1.2.3.1 Product launches & approvals
      • 16.1.2.4 MnM view
        • 16.1.2.4.1 Right to win
        • 16.1.2.4.2 Strategic choices
        • 16.1.2.4.3 Weaknesses and competitive threats
    • 16.1.3 MERCK KGAA
      • 16.1.3.1 Business overview
      • 16.1.3.2 Products/Services offered
      • 16.1.3.3 Recent developments
        • 16.1.3.3.1 Product launches
        • 16.1.3.3.2 Deals
        • 16.1.3.3.3 Expansions
      • 16.1.3.4 MnM view
        • 16.1.3.4.1 Right to win
        • 16.1.3.4.2 Strategic choices
        • 16.1.3.4.3 Weaknesses and competitive threats
    • 16.1.4 BECTON, DICKINSON AND COMPANY (BD)
      • 16.1.4.1 Business overview
      • 16.1.4.2 Products offered
      • 16.1.4.3 Recent developments
        • 16.1.4.3.1 Expansions
      • 16.1.4.4 MnM view
        • 16.1.4.4.1 Right to win
        • 16.1.4.4.2 Strategic choices
        • 16.1.4.4.3 Weaknesses and competitive threats
    • 16.1.5 NEOGEN CORPORATION
      • 16.1.5.1 Business overview
      • 16.1.5.2 Products/Services offered
      • 16.1.5.3 Recent developments
        • 16.1.5.3.1 Product/Service launches and approvals
        • 16.1.5.3.2 Deals
      • 16.1.5.4 MnM view
        • 16.1.5.4.1 Right to win
        • 16.1.5.4.2 Strategic choices
        • 16.1.5.4.3 Weaknesses and competitive threats
    • 16.1.6 QIAGEN
      • 16.1.6.1 Business overview
      • 16.1.6.2 Products offered
      • 16.1.6.3 Recent developments
        • 16.1.6.3.1 Product launches
    • 16.1.7 BIO-RAD LABORATORIES, INC.
      • 16.1.7.1 Business overview
      • 16.1.7.2 Products/Services offered
      • 16.1.7.3 Recent developments
        • 16.1.7.3.1 Product launches
    • 16.1.8 BRUKER
      • 16.1.8.1 Business overview
      • 16.1.8.2 Products/Services offered
      • 16.1.8.3 Recent developments
        • 16.1.8.3.1 Deals
    • 16.1.9 SHIMADZU CORPORATION
      • 16.1.9.1 Business overview
      • 16.1.9.2 Products/Services offered
      • 16.1.9.3 Recent developments
        • 16.1.9.3.1 Product/Service launches and approvals
        • 16.1.9.3.2 Expansions
    • 16.1.10 CHARLES RIVER LABORATORIES
      • 16.1.10.1 Business overview
      • 16.1.10.2 Products/Services offered
      • 16.1.10.3 Recent developments
        • 16.1.10.3.1 Product/Service launches and approvals
    • 16.1.11 EUROFINS SCIENTIFIC
      • 16.1.11.1 Business overview
      • 16.1.11.2 Products/Services offered
      • 16.1.11.3 Recent developments
        • 16.1.11.3.1 Deals
    • 16.1.12 IDEXX
      • 16.1.12.1 Business overview
      • 16.1.12.2 Products/Services offered
      • 16.1.12.3 Recent developments
        • 16.1.12.3.1 Product/Service launches and approvals
  • 16.2 OTHER PLAYERS
    • 16.2.1 HARDY DIAGNOSTICS
    • 16.2.2 CHARM SCIENCES
    • 16.2.3 MICROBIOLOGICS
    • 16.2.4 LIOFILCHEM S.R.L.
    • 16.2.5 R-BIOPHARM
    • 16.2.6 ROMER LABS DIVISION HOLDING
    • 16.2.7 HYGIENA LLC
    • 16.2.8 HIMEDIA LABORATORIES
    • 16.2.9 CONDALAB
    • 16.2.10 E&O LABORATORIES LTD
    • 16.2.11 MAST GROUP LTD.
    • 16.2.12 MEDICAL WIRE & EQUIPMENT
    • 16.2.13 HACH

17 RESEARCH METHODOLOGY

  • 17.1 RESEARCH DATA
  • 17.2 RESEARCH APPROACH
    • 17.2.1 SECONDARY DATA
      • 17.2.1.1 Key secondary sources
      • 17.2.1.2 Key data from secondary sources
    • 17.2.2 PRIMARY DATA
      • 17.2.2.1 Primary sources
      • 17.2.2.2 Key data from primary sources
      • 17.2.2.3 Key industry insights
      • 17.2.2.4 Breakdown of primary interviews
  • 17.3 MARKET SIZE ESTIMATION
    • 17.3.1 BOTTOM-UP APPROACH
      • 17.3.1.1 Approach 1: Company revenue estimation approach
      • 17.3.1.2 Approach 2: Presentations of companies and primary interviews
      • 17.3.1.3 Growth forecast
      • 17.3.1.4 CAGR projections
    • 17.3.2 TOP-DOWN APPROACH
  • 17.4 DATA TRIANGULATION
  • 17.5 MARKET SHARE ASSESSMENT
  • 17.6 RESEARCH ASSUMPTIONS
    • 17.6.1 PARAMETRIC ASSUMPTIONS
  • 17.7 RESEARCH LIMITATIONS
  • 17.8 RISK ASSESSMENT

18 APPENDIX

  • 18.1 DISCUSSION GUIDE
  • 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 18.3 CUSTOMIZATION OPTIONS
  • 18.4 RELATED REPORTS
  • 18.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 INCLUSIONS AND EXCLUSIONS
  • TABLE 2 US: FOOD RECALLS IN AND REASONS, 2023
  • TABLE 3 US: FOOD RECALLS, BY SPECIES, 2023
  • TABLE 4 TOP INNOVATIONS IN FOOD TESTING TECHNOLOGY
  • TABLE 5 INTERCONNECTED MARKETS
  • TABLE 6 KEY MOVES AND STRATEGIC FOCUS
  • TABLE 7 IMPACT OF PORTER'S FIVE FORCES ON MICROBIOLOGY TESTING MARKET
  • TABLE 8 GDP PERCENTAGE CHANGE, BY KEY COUNTRIES, 2023-2030
  • TABLE 9 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 10 EUROPE: MACROECONOMIC INDICATORS
  • TABLE 11 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 12 LATIN AMERICA: MACROECONOMIC INDICATORS
  • TABLE 13 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
  • TABLE 14 MICROBIOLOGY TESTING MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 15 AVERAGE SELLING PRICING TREND OF MICROBIOLOGY TESTING, BY PRODUCT, 2024-2026 (USD)
  • TABLE 16 AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING, BY KEY PLAYER, 2024-2026 (USD)
  • TABLE 17 AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING PRODUCTS, BY REGION, 2024-2026 (USD)
  • TABLE 18 IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 19 EXPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 20 MICROBIOLOGY TESTING MARKET: KEY CONFERENCES AND EVENTS, 2026-2027
  • TABLE 21 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 22 LIST OF MAJOR PATENTS PERTAINING TO MICROBIOLOGY TESTING MARKET, 2023-2025
  • TABLE 23 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 24 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 25 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 26 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 27 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 28 GLOBAL STANDARDS IN THE MICROBIOLOGY TESTING MARKET
  • TABLE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
  • TABLE 30 KEY BUYING CRITERIA, BY PRODUCT
  • TABLE 31 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • TABLE 32 MICROBIOLOGY TESTING MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
  • TABLE 33 MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 34 KEY INSTRUMENTS IN MICROBIOLOGY TESTING INSTRUMENTS MARKET
  • TABLE 35 MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 36 MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 37 NORTH AMERICA: MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 38 EUROPE: MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 39 ASIA PACIFIC: MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 40 LATIN AMERICA: MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 41 MICROBIOLOGY TESTING INCUBATORS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 42 NORTH AMERICA: MICROBIOLOGY TESTING INCUBATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 43 EUROPE: MICROBIOLOGY TESTING INCUBATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 44 ASIA PACIFIC: MICROBIOLOGY TESTING INCUBATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 45 LATIN AMERICA: MICROBIOLOGY TESTING INCUBATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 46 MICROSCOPES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 47 NORTH AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 48 EUROPE: MICROSCOPES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 49 ASIA PACIFIC: MICROSCOPES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 50 LATIN AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 51 COLONY COUNTERS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 52 NORTH AMERICA: COLONY COUNTERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 53 EUROPE: COLONY COUNTERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: COLONY COUNTERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 55 LATIN AMERICA: COLONY COUNTERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 56 MASS SPECTROMETERS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 57 NORTH AMERICA: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 58 EUROPE: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 59 ASIA PACIFIC: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 60 LATIN AMERICA: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 61 AUTOMATED CULTURE SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 62 NORTH AMERICA: AUTOMATED CULTURE SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 63 EUROPE: AUTOMATED CULTURE SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 64 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR AUTOMATED CULTURE SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 65 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR AUTOMATED CULTURE SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 66 OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 67 NORTH AMERICA: OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 68 EUROPE: OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 69 ASIA PACIFIC: OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 70 LATIN AMERICA: OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 71 KEY REAGENTS & KITS IN MICROBIOLOGY TESTING INSTRUMENTS MARKET
  • TABLE 72 MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 73 NORTH AMERICA: MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 74 EUROPE: MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 76 LATIN AMERICA: MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 77 KEY CONSUMABLES IN MICROBIOLOGY TESTING INSTRUMENTS MARKET
  • TABLE 78 MICROBIOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 79 NORTH AMERICA: MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 80 EUROPE: MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 81 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 82 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 83 US: PHARMA INCUBATOR INSTALLED BASE VOLUME, 2024-2031 (UNITS)
  • TABLE 84 MICROBIOLOGY TESTING TECHNOLOGY MARKET, BY TECHNOLOGY TYPE, 2024-2031 (USD MILLION)
  • TABLE 85 TYPES OF TECHNOLOGIES USED IN VARIOUS TRADITIONAL MICROBIOLOGY METHODS (TMM)
  • TABLE 86 TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 87 TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 88 NORTH AMERICA: TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 89 EUROPE: TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 90 ASIA PACIFIC: TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 91 LATIN AMERICA: TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 92 CULTURE METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 93 NORTH AMERICA: CULTURE METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 94 EUROPE: CULTURE METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: CULTURE METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 96 LATIN AMERICA: CULTURE METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 97 MICROSCOPY METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 98 NORTH AMERICA: MICROSCOPY METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 99 EUROPE: MICROSCOPY METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 100 ASIA PACIFIC: MICROSCOPY METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 101 LATIN AMERICA: MICROSCOPY METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 102 MANUAL COUNTING METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 103 NORTH AMERICA: MANUAL COUNTING METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 104 EUROPE: MANUAL COUNTING METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: MANUAL COUNTING METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 106 LATIN AMERICA: MANUAL COUNTING METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 107 STAINING TECHNIQUES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 108 NORTH AMERICA: STAINING TECHNIQUES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 109 EUROPE: STAINING TECHNIQUES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: STAINING TECHNIQUES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 111 LATIN AMERICA: STAINING TECHNIQUES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 112 OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 113 NORTH AMERICA: OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 114 EUROPE: OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 115 ASIA PACIFIC: OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 116 LATIN AMERICA: OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 117 TYPES OF TECHNOLOGIES USED IN VARIOUS RAPID MICROBIOLOGY METHODS (RMM)
  • TABLE 118 RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 119 RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 120 NORTH AMERICA: RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 121 EUROPE: RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 122 ASIA PACIFIC: RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 123 LATIN AMERICA: RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 124 GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 125 NORTH AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 126 EUROPE: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 128 LATIN AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 129 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 130 NORTH AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 131 EUROPE: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 133 LATIN AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 134 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 135 NORTH AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 136 EUROPE: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 138 LATIN AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 139 VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 140 NORTH AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 141 EUROPE: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 143 LATIN AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 144 MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 145 BACTERIAL TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 146 NORTH AMERICA: BACTERIAL TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 147 EUROPE: BACTERIAL TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: BACTERIAL TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 149 LATIN AMERICA: BACTERIAL TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 150 VIRAL TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 151 NORTH AMERICA: VIRAL TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 152 EUROPE: VIRAL TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: VIRAL TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 154 LATIN AMERICA: VIRAL TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 155 FUNGAL TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 156 NORTH AMERICA: FUNGAL TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 157 EUROPE: FUNGAL TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: FUNGAL TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 159 LATIN AMERICA: FUNGAL TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 160 OTHER PATHOGEN TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 161 NORTH AMERICA: OTHER PATHOGEN TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 162 EUROPE: OTHER PATHOGEN TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 163 ASIA PACIFIC: OTHER PATHOGEN TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 164 LATIN AMERICA: OTHER PATHOGEN TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 165 MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 166 MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 167 NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 168 EUROPE: MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 169 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 170 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 171 MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 172 NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 173 EUROPE: MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 174 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 175 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 176 MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 177 NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 178 EUROPE: MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 179 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 180 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 181 MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 182 NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 183 EUROPE: MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 184 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 185 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 186 MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 187 NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 188 EUROPE: MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 189 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 190 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 191 MICROBIOLOGY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 192 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 193 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 194 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 195 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 196 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY END USERS, 2024-2031 (USD MILLION)
  • TABLE 197 US: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 198 US: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 199 US: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 200 US: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 201 CANADA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 202 CANADA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 203 CANADA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 204 CANADA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 205 EUROPE: MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 206 EUROPE: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 207 EUROPE: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 208 EUROPE: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 209 EUROPE: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 210 GERMANY: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 211 GERMANY: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 212 GERMANY: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 213 GERMANY: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 214 UK: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 215 UK: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 216 UK: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 217 UK: MICROBIOLOGY TESTING MARKET, BY END USERS, 2024-2031 (USD MILLION)
  • TABLE 218 FRANCE: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 219 FRANCE: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 220 FRANCE: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 221 FRANCE: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 222 ITALY: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 223 ITALY: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 224 ITALY: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 225 ITALY: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 226 SPAIN: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 227 SPAIN: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 228 SPAIN: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 229 SPAIN: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 230 REST OF EUROPE: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 231 REST OF EUROPE: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 232 REST OF EUROPE: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 233 REST OF EUROPE: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 234 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 235 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 236 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 237 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 238 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 239 CHINA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 240 CHINA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 241 CHINA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 242 CHINA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 243 JAPAN: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 244 JAPAN: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 245 JAPAN: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 246 JAPAN: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 247 INDIA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 248 INDIA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 249 INDIA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 250 INDIA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 251 SOUTH KOREA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 252 SOUTH KOREA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 253 SOUTH KOREA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 254 SOUTH KOREA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 255 AUSTRALIA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 256 AUSTRALIA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 257 AUSTRALIA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 258 AUSTRALIA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 259 REST OF ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 260 REST OF ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 261 REST OF ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 262 REST OF ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 263 LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 264 LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 265 LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 266 LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 267 LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 268 BRAZIL: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 269 BRAZIL: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 270 BRAZIL: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 271 BRAZIL: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 272 MEXICO: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 273 MEXICO: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 274 MEXICO: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 275 MEXICO: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 276 REST OF LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 277 REST OF LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 278 REST OF LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 279 REST OF LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 280 MIDDLE EAST & AFRICA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 281 MIDDLE EAST & AFRICA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 282 MIDDLE EAST & AFRICA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024-2031 (USD MILLION)
  • TABLE 283 MIDDLE EAST & AFRICA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 284 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022-2025
  • TABLE 285 MICROBIOLOGY TESTING MARKET: DEGREE OF COMPETITION
  • TABLE 286 REGIONAL FOOTPRINT, 2025
  • TABLE 287 PRODUCT FOOTPRINT, 2025
  • TABLE 288 TECHNOLOGY FOOTPRINT
  • TABLE 289 END USER FOOTPRINT, 2025
  • TABLE 290 LIST OF STARTUPS/SMES, 2025
  • TABLE 291 MICROBIOLOGY TESTING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2), 2025
  • TABLE 292 MICROBIOLOGY TESTING MARKET COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2), 2025
  • TABLE 293 MICROBIOLOGY TESTING MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-DECEMBER 2025
  • TABLE 294 MICROBIOLOGY TESTING MARKET: DEALS, JANUARY 2022-DECEMBER 2025
  • TABLE 295 MICROBIOLOGY TESTING MARKET: EXPANSION, JANUARY 2022-DECEMBER 2025
  • TABLE 296 BIOMERIEUX: COMPANY OVERVIEW
  • TABLE 297 BIOMERIEUX: PRODUCTS OFFERED
  • TABLE 298 BIOMERIEUX: PRODUCT LAUNCHES AND APPROVALS
  • TABLE 299 BIOMERIEUX: DEALS
  • TABLE 300 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 301 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 302 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES AND APPROVALS
  • TABLE 303 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 304 MERCK KGAA: PRODUCTS/SERVICES OFFERED
  • TABLE 305 MERCK KGAA: PRODUCT LAUNCHES
  • TABLE 306 MERCK KGAA: DEALS
  • TABLE 307 MERCK KGAA: EXPANSIONS
  • TABLE 308 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW
  • TABLE 309 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED
  • TABLE 310 BECKTON, DICKINSON AND COMPANY: EXPANSIONS
  • TABLE 311 NEOGEN CORPORATION: COMPANY OVERVIEW
  • TABLE 312 NEOGEN CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 313 NEOGEN CORPORATION: PRODUCT/SERVICE LAUNCHES
  • TABLE 314 NEOGEN CORPORATION: DEALS
  • TABLE 315 QIAGEN: COMPANY OVERVIEW
  • TABLE 316 MCKESSON CORPORATION: PRODUCTS OFFERED
  • TABLE 317 QIAGEN N.V.: PRODUCT LAUNCHES
  • TABLE 318 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 319 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 320 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES
  • TABLE 321 BRUKER: COMPANY OVERVIEW
  • TABLE 322 BRUKER: PRODUCTS/SERVICES OFFERED
  • TABLE 323 BRUKER: DEALS
  • TABLE 324 SHIMADZU CORPORATION: COMPANY OVERVIEW
  • TABLE 325 SHIMADZU CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 326 SHIMADZU CORPORATION: PRODUCT/SERVICE LAUNCHES AND APPROVALS
  • TABLE 327 SHIMADZU CORPORATION: EXPANSIONS
  • TABLE 328 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
  • TABLE 329 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED
  • TABLE 330 CHARLES RIVER LABORATORIES: PRODUCT/SERVICE LAUNCHES
  • TABLE 331 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 332 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
  • TABLE 333 EUROFINS SCIENTIFIC: DEALS
  • TABLE 334 IDEXX: COMPANY OVERVIEW
  • TABLE 335 IDEXX: PRODUCTS/SERVICES OFFERED
  • TABLE 336 IDEXX: PRODUCT/SERVICE LAUNCHES AND APPROVALS
  • TABLE 337 HARDY DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 338 CHARM SCIENCES: COMPANY OVERVIEW
  • TABLE 339 MICROBIOLOGICS: COMPANY OVERVIEW
  • TABLE 340 LIOFILCHEM S.R.L. : COMPANY OVERVIEW
  • TABLE 341 R-BIOPHARM: COMPANY OVERVIEW
  • TABLE 342 ROMER LABS DIVISION HOLDING: COMPANY OVERVIEW
  • TABLE 343 HYGIENA LLC: COMPANY OVERVIEW
  • TABLE 344 HIMEDIA LABORATORIES: COMPANY OVERVIEW
  • TABLE 345 CONDALAB: COMPANY OVERVIEW
  • TABLE 346 E&O LABORATORIES LTD: COMPANY OVERVIEW
  • TABLE 347 MAST GROUP LTD.: COMPANY OVERVIEW
  • TABLE 348 MEDICAL WIRE & EQUIPMENT: COMPANY OVERVIEW
  • TABLE 349 HACH: COMPANY OVERVIEW
  • TABLE 350 MICROBIOLOGY TESTING MARKET: KEY DATA FROM PRIMARY SOURCES
  • TABLE 351 RISK ASSESSMENT

List of Figures

  • FIGURE 1 MICROBIOLOGY TESTING MARKET SEGMENTATION
  • FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MICROBIOLOGY TESTING MARKET, 2022-2025
  • FIGURE 4 DISRUPTIVE TRENDS IMPACTING GROWTH OF MICROBIOLOGY TESTING MARKET
  • FIGURE 5 FASTEST-GROWTH SEGMENTS AND EMERGING FRONTIERS IN MICROBIOLOGY TESTING MARKET
  • FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 7 GROWING NEED FOR CONTAMINATION CONTROL TO DRIVE MARKET
  • FIGURE 8 REAGENT & KITS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 9 TRADITIONAL MICROBIOLOGY METHODS (TMM) TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 10 BACTERIAL TESTING TO CONTINUE LEAD SIGNIFICANTLY DURING FORECAST PERIOD
  • FIGURE 11 PHARMACEUTICAL & BIOTECH COMPANIES TO COMMAND LARGEST SHARE AMONG END USERS DURING FORECAST PERIOD
  • FIGURE 12 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 13 MICROBIOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 14 PRODUCTS RECALLED GLOBALLY, 2012-2022
  • FIGURE 15 MICROBIOLOGY TESTING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 16 MICROBIOLOGY TESTING MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 17 MICROBIOLOGY TESTING MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 18 MICROBIOLOGY TESTING MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 19 MICROBIOLOGY TESTING MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 20 NUMBER OF DEALS & FUNDING ACTIVITIES IN MICROBIOLOGY TESTING MARKET
  • FIGURE 21 PATENT ANALYSIS FOR MICROBIOLOGY TESTING, JANUARY 2016-DECEMBER 2025
  • FIGURE 22 MARKET POTENTIAL OF AI IN MICROBIOLOGY TESTING MARKET
  • FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
  • FIGURE 24 KEY BUYING CRITERIA, BY PRODUCT
  • FIGURE 25 NORTH AMERICA: MICROBIOLOGY TESTING MARKET SNAPSHOT
  • FIGURE 26 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET SNAPSHOT
  • FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS, 2022-2024 (USD MILLION)
  • FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
  • FIGURE 29 US MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
  • FIGURE 30 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 31 COMPANY FOOTPRINT, 2025
  • FIGURE 32 COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK BETA OF KEY VENDORS, 2025
  • FIGURE 34 EV/EBITDA OF KEY VENDORS, 2025
  • FIGURE 35 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 36 BIOMERIEUX: COMPANY SNAPSHOT (2024)
  • FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2024)
  • FIGURE 39 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024)
  • FIGURE 40 NEOGEN CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 41 QIAGEN: COMPANY SNAPSHOT (2024)
  • FIGURE 42 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 43 BRUKER: COMPANY SNAPSHOT (2024)
  • FIGURE 44 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 45 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024)
  • FIGURE 46 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024)
  • FIGURE 47 IDEXX: COMPANY SNAPSHOT (2024)
  • FIGURE 48 MICROBIOLOGY TESTING MARKET: RESEARCH DESIGN METHODOLOGY
  • FIGURE 49 KEY DATA FROM SECONDARY SOURCES
  • FIGURE 50 PRIMARY SOURCES
  • FIGURE 51 INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 52 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
  • FIGURE 53 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 54 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 55 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
  • FIGURE 56 MICROBIOLOGY TESTING MARKET: TOP-DOWN APPROACH
  • FIGURE 57 DATA TRIANGULATION METHODOLOGY
  • FIGURE 58 MICROBIOLOGY TESTING MARKET: RESEARCH ASSUMPTIONS